Report
Vanda puts social anxiety drug program on hold after late-stage study misses main goal
Reuters reports Vanda put the program on hold pending further analysis of the study data.
TLDR
Reuters reports Vanda Pharmaceuticals said its experimental drug for social anxiety disorder failed the main goal of a late-stage study. The company put the program on hold pending further analysis of the data.
Combined views
35.8K
1 Source, first seen ago